Caabuqa HIV HCV HBSAG IYO Baaritaanka Isku-dhafka Degdegga ah ee waraabowga
MACLUUMAADKA SOO SAARKA
| Nambarka Model | HBsAg/TP&HIV/HCV | Baakad | 20 Tijaabooyin/xirmo, 30kits/CTN |
| Magaca | HBsAg/TP&HIV/HCV Tijaabada Combo Degdega ah | Kala soocidda qalabka | Fasalka III |
| Astaamaha | Dareen sare, hawl fudud | Shahaado | CE/ ISO13485 |
| Saxnaanta | > 97% | Nolosha shelf | Laba Sano |
| Habka | Dahabka Colloidal | OEM/ODM adeegga | La heli karo |
Sarraynta
Waqtiga tijaabada: 15-20 daqiiqo
Kaydinta:2-30℃/36-86℉
Habka: Colloidal Gold
Tilmaam:
• xasaasi sare
• natiijada akhriska 15-20 daqiiqo gudahood
• Hawlgal fudud
• Saxnaanta sare
ISTICMAALKA KULA JIRA
Qalabkani waxa uu ku haboon yahay in vitro lagu go'aamiyo tayada fayraska cagaarshow B, waraabowga spirochete, fayraska difaaca jirka, iyo fayraska cagaarshow C ee ku jira serum/plas.muunadaha dhiiga oo dhan ee lagu ogaanayo kaaliyaha fayraska cagaarshow B, waraabowga spirochete, fayraska difaaca jirka bini'aadamka, iyo caabuqyada fayraska cagaarshowga C. Natiijooyinka la helay waa inlagu falanqeeyo iyada oo lala kaashanayo macluumaadka kale ee kiliinikada. Waxaa loogu talagalay inay isticmaalaan xirfadlayaasha caafimaadka oo keliya.
Habka tijaabada
| 1 | U akhri tilmaamaha isticmaalka oo si adag u raac tilmaamaha isticmaalka qalliinka loo baahan yahay si aad uga fogaato inay saamayso saxnaanta natiijooyinka imtixaanka |
| 2 | Baaritaanka ka hor, xirmada iyo muunada waxaa laga soo saarayaa xaalada kaydinta waxaana la isku dheelitiraa heerkulka qolka oo calaamadee. |
| 3 | Jeexitaanka baakadaha shandad bireed aluminium ah, ka soo saar qalabka tijaabada oo calaamadee, ka dibna si siman u dul dhig miiska tijaabada. |
| 4 | Saambalada serum/balaasmaha oo leh dhibco la tuuri karo oo ku dar 2 dhibcood mid kasta oo ka mid ah ceelasha s1 iyo s2; ku dar 3 dhibcood mid kasta oo ka mid ah ceelasha s1 iyo s2 ee muunada dhiiga oo dhan ka hor intaadan ku darin 1 ~ 2 dhibcood oo xal ah ceelasha s1 iyo s2 mid kasta oo wakhtiga la bilaabay |
| 5 | Natiijooyinka baaritaanka waa in lagu tarjumaa 15 ~ 20 daqiiqo gudahood, haddii in ka badan 20 daqiiqo natiijadu ay khaldan tahay. |
| 6 | Turjumaada muuqaalka waxa loo isticmaali karaa tarjumaada natiijada. |
Fiiro gaar ah: muunad kasta waa in lagu shubaa pipette nadiif ah oo la tuuri karo si looga fogaado wasakhaynta isdhaafka ah.
WAXQABADKA CALIMADDA
| Natiijooyinka WIZHBsag
| Natiijada tijaabada ee reagent Reference | Heerka shilka togan:99.06% (95% CI 96.64% ~ 99.74%) Heerka shilka xun:98.69% (95% CI96.68% ~ 99.49%) Wadarta heerka shilka:98.84% (95%CI97.50%~99.47% | ||
| Wanagsan | xun | Wadarta | ||
| Togan | 211 | 4 | 215 | |
| xun | 2 | 301 | 303 | |
| Wadarta | 213 | 305 | 518 | |
| Natiijooyinka WIZTP
| Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:96.18% (95% CI 91.38% ~ 98.36%) Heerka shilka xun:97.67% (95% CI95.64% ~ 98.77%) Wadarta heerka shilka:97.30% (95% CI95.51% ~ 98.38%) | ||
| Wanagsan | xun | Wadarta | ||
| Togan | 126 | 9 | 135 | |
| xun | 5 | 378 | 383 | |
| Wadarta | 131 | 387 | 518 | |
| Natiijooyinka WIZHCV
| Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:93.44% (95% CI 84.32% ~ 97.42%) Heerka shilka xun:99.56% (95% CI98.42% ~ 99.88%) Wadarta heerka shilka:98.84% (95% CI97.50% ~ 99.47%) | ||
| Wanagsan | xun | Wadarta | ||
| Togan | 57 | 2 | 59 | |
| xun | 4 | 455 | 459 | |
| Wadarta | 61 | 457 | 518 | |
| Natiijooyinka WIZHIV
| Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:96.81% (95% CI 91.03% ~ 98.91%) Heerka shilka xun:99.76% (95% CI98.68% ~ 99.96%) Wadarta heerka shilka:99.23% (95% CI98.03% ~ 99.70%) | ||
| Wanagsan | xun | Wadarta | ||
| Togan | 91 | 1 | 92 | |
| xun | 3 | 423 | 446 | |
| Wadarta | 94 | 424 | 518 | |
